IN2015DN02930A - - Google Patents

Info

Publication number
IN2015DN02930A
IN2015DN02930A IN2930DEN2015A IN2015DN02930A IN 2015DN02930 A IN2015DN02930 A IN 2015DN02930A IN 2930DEN2015 A IN2930DEN2015 A IN 2930DEN2015A IN 2015DN02930 A IN2015DN02930 A IN 2015DN02930A
Authority
IN
India
Prior art keywords
luliconazole
pharmaceutical formulation
specifying
establish
prepare
Prior art date
Application number
Other languages
English (en)
Inventor
Takaaki; Masuda
Hiroshi; Yamaguchi
Original Assignee
Pola Pharma Inc
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc, Nihon Nohyaku Co Ltd filed Critical Pola Pharma Inc
Publication of IN2015DN02930A publication Critical patent/IN2015DN02930A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN2930DEN2015 2012-09-14 2013-02-19 IN2015DN02930A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012202696A JP5460797B1 (ja) 2012-09-14 2012-09-14 アミド誘導体及び安定性指標としてのその使用
PCT/JP2013/055025 WO2014041825A1 (en) 2012-09-14 2013-02-19 Amide derivative and use of the same as stability index of a luliconazole pharmaceutical formulation

Publications (1)

Publication Number Publication Date
IN2015DN02930A true IN2015DN02930A (enExample) 2015-09-18

Family

ID=47884458

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2930DEN2015 IN2015DN02930A (enExample) 2012-09-14 2013-02-19

Country Status (7)

Country Link
US (1) US9145401B2 (enExample)
EP (1) EP2895480A1 (enExample)
JP (1) JP5460797B1 (enExample)
CN (1) CN104662017A (enExample)
IN (1) IN2015DN02930A (enExample)
RU (1) RU2612557C2 (enExample)
WO (1) WO2014041825A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5635075B2 (ja) 2009-08-25 2014-12-03 株式会社ポーラファルマ 抗真菌医薬組成物
EP2579847A1 (en) 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN104284662A (zh) 2012-09-14 2015-01-14 宝丽制药股份有限公司 晶体及包含该晶体的药物制剂
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
CN104619703A (zh) 2012-09-14 2015-05-13 宝丽制药股份有限公司 具有结晶习性的晶体以及通过对所述晶体进行加工获得的药物组合物
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5926756B2 (ja) * 2014-03-26 2016-05-25 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5623671B1 (ja) * 2014-07-23 2014-11-12 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
EP3230280A4 (en) * 2014-12-12 2018-05-09 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
JP7259873B2 (ja) * 2019-02-07 2023-04-18 株式会社島津製作所 分析方法、分析装置およびプログラム

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
DE19681478B4 (de) 1995-07-08 2006-09-21 Nihon Nohyaku Co., Ltd. R-(-)-(E)-[4-(2,4-Dichlorphenyl)-1,3-dithiolan-2-yliden]-1-imidazolylacetonitril,Verfahren zu seiner Herstellung und seine Verwendung
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
JP5184342B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
US8268876B2 (en) 2006-03-08 2012-09-18 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
BRPI0621446C1 (pt) 2006-03-08 2021-05-25 Nihon Nohyaku Co Ltd composição farmacêutica para uso externo
WO2009031643A1 (ja) * 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
EP2191826B1 (en) 2007-09-05 2017-03-08 Pola Pharma Inc. Pharmaceutical composition
EP2191828B1 (en) 2007-09-05 2016-08-10 Pola Pharma Inc. Antifungal pharmaceutical composition
JP5654497B2 (ja) * 2009-02-13 2015-01-14 トピカ ファーマシューティカルズ，インコーポレイテッド 抗真菌製剤
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5635075B2 (ja) 2009-08-25 2014-12-03 株式会社ポーラファルマ 抗真菌医薬組成物
EP2579847A1 (en) * 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
RU2621615C2 (ru) 2012-09-14 2017-06-06 Пола Фарма Инк. Фармацевтическая композиция, содержащая луликоназол
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
CN104284662A (zh) 2012-09-14 2015-01-14 宝丽制药股份有限公司 晶体及包含该晶体的药物制剂
CN104619703A (zh) 2012-09-14 2015-05-13 宝丽制药股份有限公司 具有结晶习性的晶体以及通过对所述晶体进行加工获得的药物组合物
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質

Also Published As

Publication number Publication date
JP5460797B1 (ja) 2014-04-02
WO2014041825A1 (en) 2014-03-20
CN104662017A (zh) 2015-05-27
RU2015113587A (ru) 2016-11-10
US9145401B2 (en) 2015-09-29
US20150191456A1 (en) 2015-07-09
EP2895480A1 (en) 2015-07-22
JP2014058449A (ja) 2014-04-03
RU2612557C2 (ru) 2017-03-09

Similar Documents

Publication Publication Date Title
IN2015DN02930A (enExample)
PH12015501996A1 (en) Heterocyclic compounds and uses thereof
IN2015MN00405A (enExample)
CR20140464A (es) Compuestos de heterociclilo
CU20140089A7 (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CU20140081A7 (es) Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CU20140095A7 (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
MX2021001231A (es) Compuestos heterociclicos y sus usos.
UA114657C2 (uk) Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2
CO7350620A2 (es) Nuevos derivados de piridina
CR20150470A (es) Derivados de triazolona de piridinilo y piridinilo fusionado
UY35467A (es) Compuestos orgánicos
MX2015009719A (es) Inhibidores benzoquinolona de vmat2.
PH12019501178A1 (en) Thiopene derivatives as antiviral agents
MY174000A (en) Novel pyridine derivatives
PH12018502556A1 (en) Cosmetic base including amide alcohol, and cosmetic
CR20150555A (es) Nuevos derivados de pirrolo[2,3-d]pirimidina
UY35997A (es) Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
IN2015DN00950A (enExample)
MX2013007726A (es) Derivados de 2-metoxi-piridin-4-ilo.
CY1119984T1 (el) Σταθεροποιημενη αμορφη μορφη αγομελατινης, μια μεθοδος για την παρασκευη της και φαρμακευτικες συνθεσεις που την περιεχουν
PH12018502555A1 (en) Cosmetic base including amide alcohol ester, and cosmetic
UY35958A (es) Derivados de quinolina como insecticidas y acaricidas
MX362994B (es) Preparacion farmaceutica que comprende un derivado de aminopirazol.